Background and objective: The differentiation of mild cognitive impairment (MCI), which is the prodromal stage of Alzheimer disease (AD), from normal control (NC) is important as the recent research emphasis on early pre-clinical stage for possible disease abnormality identification, intervention and even possible prevention.